Philippines Business News API

{
    "totalArticles": 315830,
    "articles": [
        {
            "id": "7ce1dc822b2caa18faa315d095df6cf1",
            "title": "Kadant Authorizes Share Repurchase",
            "description": "WESTFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has authorized the repurchase of up to $50 million of its equity securities effective May 21, 2026 through May 21, 2027. Repurchases may be made in public or private transactions, including under Securities Exchange Act Rule 10b-5-1 trading plans. The timing and amount of any repurchases will be at the discretion of Company management and will be based on market conditions and other considerations, including limitations contained in our credit agreement entered into on March 1, 2017, as amended and restated. The Company has not repurchased any shares of its common stock under the $50 million authorization that expired on May 15, 2026.",
            "content": "WESTFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has authorized the repurchase of up to $50 million of its equity securities effective May 21, 2026 through May 21, 2027. Repurchases... [3894 chars]",
            "url": "https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/kadant-authorizes-share-repurchase/2349668",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/22/1067725.jpg",
            "publishedAt": "2026-05-21T20:40:14Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "2d29d2c3026ce656562c41fc71e4f376",
            "title": "OFA Group Transitions to U.S. Domestic Issuer Status; Reaffirms United States as the Center of Its Growth Strategy",
            "description": "Torrance, California, May 21, 2026 (GLOBE NEWSWIRE) -- OFA Group (NASDAQ: OFAL) ('OFA Group' or the 'Company') today announced that, effective April 1, 2026, the Company ceased to qualify as a 'foreign private issuer' within the meaning of Rule 405 under the Securities Act of 1933 and Rule 3b-4 under the Securities Exchange Act of 1934, and now reports as a U.S. domestic issuer under the Securities and Exchange Commission's rules applicable to domestic registrants.",
            "content": "Torrance, California, May 21, 2026 (GLOBE NEWSWIRE) -- OFA Group (NASDAQ: OFAL) (\"OFA Group\" or the \"Company\") today announced that, effective April 1, 2026, the Company ceased to qualify as a \"foreign private issuer\" within the meaning of Rule 405 u... [5763 chars]",
            "url": "https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/ofa-group-transitions-to-us-domestic-issuer-status-reaffirms-united-states-as-the-center-of-its-growth-strategy/2349663",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/22/1067714.png",
            "publishedAt": "2026-05-21T20:40:01Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "c91018287aa50c106d432f81d13ddc91",
            "title": "Adaptive Biotechnologies to Participate in Upcoming Investor Conferences",
            "description": "SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.",
            "content": "SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat dis... [2037 chars]",
            "url": "https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences/2349658",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/22/1067711.jpg",
            "publishedAt": "2026-05-21T20:19:56Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}